ArticleOncoTargets and therapy2019

Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations.

Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.